0001209191-19-060910.txt : 20191217
0001209191-19-060910.hdr.sgml : 20191217
20191217170436
ACCESSION NUMBER: 0001209191-19-060910
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191216
FILED AS OF DATE: 20191217
DATE AS OF CHANGE: 20191217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: AZAB MOHAMMAD
CENTRAL INDEX KEY: 0001309653
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36687
FILM NUMBER: 191290472
MAIL ADDRESS:
STREET 1: C/O SUPERGEN, INC.
STREET 2: 4140 DUBLIN BLVD., SUITE 200
CITY: DUBLIN
STATE: CA
ZIP: 94568
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xenon Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001582313
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980661854
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 - 3650 GILMORE WAY
CITY: BURNABY
STATE: A1
ZIP: V5G 48W
BUSINESS PHONE: (604) 484-3300
MAIL ADDRESS:
STREET 1: 200 - 3650 GILMORE WAY
CITY: BURNABY
STATE: A1
ZIP: V5G 48W
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-12-16
0
0001582313
Xenon Pharmaceuticals Inc.
XENE
0001309653
AZAB MOHAMMAD
200 - 3650 GILMORE WAY
BURNABY
A1
BRITISH COLUMBIA, CANADA
1
0
0
0
Common Shares
2019-12-16
4
M
0
3086
3.56
A
60647
D
Stock Option (Right to Buy)
3.56
2019-12-16
4
M
0
3086
0.00
D
2019-12-31
Common Shares
3086
0
D
The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.
The shares subject to the option fully vested on December 31, 2012. The date the options became fully vested was incorrectly reflected on the Reporting Person's Form 3.
/s/ Cassandra Robinson, Attorney-in-fact
2019-12-17